Comstock INC 8-K filings

Comstock Inc. has restructured its investment agreement with Quantum Generative Materials LLC (GenMat), reducing its equity stake while securing exclusive rights in the biofuel sector and non-exclusive rights in mining.

Comstock Inc. has amended and extended the maturity dates of its existing promissory notes with Alvin Fund and GHF Inc. to April 15, 2026, while also adjusting interest rates and warrant terms.

Comstock Inc. has finalized a $3 million investment in RenFuel K2B AB through convertible notes to support the development of renewable fuel technologies and a biorefinery project.

Comstock Inc. has amended its license and asset purchase agreements with American Science and Technology Corporation, shifting payment obligations to company stock and extending the deadline for a quarry purchase.

Comstock Inc. has published its first quarter 2024 stakeholder perception analysis report, providing insights into the company's operational milestones and perceived strengths and weaknesses.

Comstock Inc. has filed an amendment to its previous 8-K report to correct the purchase price definition in its equity purchase agreement with ClearThink Capital Partners LLC.

Comstock Inc. has entered into an agreement with ClearThink Capital Partners for a potential equity offering of up to $5 million.

Comstock Inc. announced record investment gains of over $25 million and a full year net income of over $10.5 million for 2023, alongside updates on strategic initiatives and a 2024 business outlook.

Comstock Inc. has extended the deadlines for finalizing transaction documents and closing its strategic investment in RenFuel, a move related to its first commercial biorefinery.